Bank of Nova Scotia
KYNB

Bank of Nova Scotia’s Kyntra Bio KYNB Stock Holding History

Bank of Nova Scotia’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-924
Closed -$615K – 1146
2021
Q2 		$615K Buy
+924
New +$532K ﹤0.01% 926
2018
Q4 		– Sell
-3,800
Closed -$5.77M – 867
2018
Q3 		$5.77M Sell
3,800
-12
-0.3% -$18.5K 0.03% 402
2018
Q2 		$5.97M Sell
3,812
-6,000
-61% -$7.82M 0.03% 329
2018
Q1 		$11.3M Buy
+9,812
New +$12.9M 0.06% 272

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of Nova Scotia's KYNB Position: Q3 2021 in Review

Bank of Nova Scotia sold out of Kyntra Bio (KYNB) in Q3 2021, closing a stake of 924 shares — an estimated $615K sold.

Bank of Nova Scotia first reported a position in KYNB in Q1 2018 and held it in 4 quarters. The position peaked at $11.3M in Q1 2018. 164 funds tracked by Wall St. Rank hold KYNB as of Q3 2021.

  • Bank of Nova Scotia reported no remaining Kyntra Bio position as of Q3 2021 after selling out during the quarter.
  • Bank of Nova Scotia sold 924 Kyntra Bio shares in Q3 2021, an estimated $615K.
  • Bank of Nova Scotia first reported a position in Kyntra Bio in Q1 2018 and held it in 4 quarters.
  • Bank of Nova Scotia's Kyntra Bio position peaked at $11.3M in Q1 2018.
  • 164 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2021.

Based on Bank of Nova Scotia's 13F filing for Q3 2021, filed 12 Nov 2021.